{"title":"胰腺癌低分割放疗:2025年将扮演什么角色?","authors":"Pauline Kordalski , Florence Huguet","doi":"10.1016/j.canrad.2025.104676","DOIUrl":null,"url":null,"abstract":"<div><div>The role of radiation therapy in the treatment of pancreatic cancer has been debated for many years. Recent advances in radiation techniques with the development of stereotactic body radiotherapy and magnetic resonance imaging-guided radiotherapy have opened new therapeutic possibilities, enabling the delivery of ablative doses while minimizing the dose received by surrounding organs at risk. In this context, the potential benefit of radiation therapy should be questioned again.</div></div>","PeriodicalId":9504,"journal":{"name":"Cancer Radiotherapie","volume":"29 5","pages":"Article 104676"},"PeriodicalIF":1.4000,"publicationDate":"2025-07-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Hypofractionated radiotherapy for pancreatic cancer: What role in 2025?\",\"authors\":\"Pauline Kordalski , Florence Huguet\",\"doi\":\"10.1016/j.canrad.2025.104676\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><div>The role of radiation therapy in the treatment of pancreatic cancer has been debated for many years. Recent advances in radiation techniques with the development of stereotactic body radiotherapy and magnetic resonance imaging-guided radiotherapy have opened new therapeutic possibilities, enabling the delivery of ablative doses while minimizing the dose received by surrounding organs at risk. In this context, the potential benefit of radiation therapy should be questioned again.</div></div>\",\"PeriodicalId\":9504,\"journal\":{\"name\":\"Cancer Radiotherapie\",\"volume\":\"29 5\",\"pages\":\"Article 104676\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-07-18\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Cancer Radiotherapie\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1278321825000927\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Radiotherapie","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1278321825000927","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"ONCOLOGY","Score":null,"Total":0}
Hypofractionated radiotherapy for pancreatic cancer: What role in 2025?
The role of radiation therapy in the treatment of pancreatic cancer has been debated for many years. Recent advances in radiation techniques with the development of stereotactic body radiotherapy and magnetic resonance imaging-guided radiotherapy have opened new therapeutic possibilities, enabling the delivery of ablative doses while minimizing the dose received by surrounding organs at risk. In this context, the potential benefit of radiation therapy should be questioned again.
期刊介绍:
Cancer/radiothérapie se veut d''abord et avant tout un organe francophone de publication des travaux de recherche en radiothérapie. La revue a pour objectif de diffuser les informations majeures sur les travaux de recherche en cancérologie et tout ce qui touche de près ou de loin au traitement du cancer par les radiations : technologie, radiophysique, radiobiologie et radiothérapie clinique.